Check out the on-demand educational recording from Africa Online Healthcare Week 2020 by clicking here. Dr Susanne Emmerich (Germany) discusses the relationship between diabetes and COVID-19, and how HbA1c point-of-care testing (POCT) impacts glycemic control in diabetic patients. Dr Carl Llor (Spain) discusses the value of C-reactive protein (CRP) POCT to aid assessment of COVID-19 and prevent unnecessary prescription of antibiotics.
View expert presentation on point-of-care testing for diabetes and in the context of COVID-19
Africa Healthcare Week Online is the largest ever virtual event for African healthcare. It features thousands of attendees, with over 80 webinar speakers, including panel discussions and case studies from ministries of health and prominent healthcare leaders.
A scientific session from the latest event (held 13–17 July 2020) covering The value of point-of-care testing in the time of COVID-19 is now available here.
The session features two renowned experts in their fields:
- Dr Susanne Emmerich (Germany) discusses HbA1c point-of-care testing (POCT) for diabetic patients to reduce risk for and severity of COVID-19
- Dr Carl Llor (Spain) discusses the value of C-reactive protein (CRP) POCT to aid assessment of COVID-19 and reduce antimicrobial resistance
- The relationship between diabetes management and COVID-19 severity
- HbA1c POCT for improving glycaemic control in diabetic patients
- Prescription of antibiotics related to COVID-19
- C-reactive protein (CRP) POCT as a tool for identifying bacterial infection in the lungs
- CRP POCT as a predictor of COVID-19 disease severity
- Inappropriate prescription of antibiotics related to COVID-19 and antimicrobial resistance
To read the learning objectives for this session, plus watch the seminar in full, please click here.
The views and opinions presented are of the author only. The content contained in this webcast is intended for informational / educational purposes only.
© 2023 애보트. 판권 소유. 참조된 모든 상표는 Abbott 그룹 회사 또는 해당 소유자의 상표입니다.
The American Diabetes Association standards of care - 2023 guidelines provide recommendations for healthcare providers regarding cardiovascular disease (CVD) and risk management in people with diabetes. The authors highlight that atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) are leading causes of morbidity and mortality for people with diabetes, noting that simultaneously addressing cardiovascular (CV) risk factors can con...
American Diabetes Association recommendations for cardiovascular disease in diabetesen지금 액세스
The Kidney Disease: Improving Global Outcomes (KIDGO) 2022 clinical practice guidelines are based on a systematic review of evidence and aim to assist health care professionals with their decision making for people with diabetes and chronic kidney disease (CKD). The authors highlight that by 2045, 784 million people are estimated to have diabetes globally, of whom ≥40% will develop CKD, potentially leading to kidney failure requiring dialysis or ...
KIDGO clinical practice guidelines: diabetes management in chronic kidney diseaseen지금 액세스
The objective of this longitudinal cohort study was to determine the prevalence of chronic kidney disease (CKD) and associated risk factors in a rural South African population. The authors note that infectious and non-communicable disease are a substantial risk for CKD in Africa, but that heterogeneity in assessment and diagnostic criteria hamper the interpretation of prevalence.
Chronic kidney disease prevalence and risks in rural South Africaen지금 액세스